Sign up to our newsletter
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
LATEST ALERTS
View all Americas
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Daily regulatory updates of legal changes in the cannabis sector, including monthly compilations
5th December 2023
US - Ohio: A Senate committee has added and approved major changes to the recreational cannabis legalisation ballot initiative approved by voters last month that is scheduled to take effect on 7th December, press reports. The emergency measure was attached to a liquor control bill and would make the following changes, among others: prohibit home cultivation of cannabis, set potency limits on cannabis products, reduce the permissible amount of cannabis that may legally be possessed, increase the cannabis excise tax from 10% to 15%, redirect tax revenues, restrict public consumption, and decrease the permissible number of dispensaries. The bill must be approved by the plenary Senate, which could vote on it this week, and then by the House.4th December 2023
- US - New York: The New York Supreme Court has approved a settlement in two lawsuits that will now allow the Office of Cannabis Management to resume processing and reviewing conditional adult-use retail dispensary programme (CAURD) licences. The approved settlement could allow for the opening of 436 dispensaries by provisional CAURD licensees.
1st December 2023
- US - Federal: The Congressional Research Service (CRS) has issued a memo entitled “Farm Bill Primer: Selected Hemp Industry Issues” that addresses several issues related to hemp provisions in the upcoming Farm Bill. The memo provides an overview of hemp production in the US, identifies several hemp interest groups and attempts to summarise what stakeholders are advocating for in the new Farm Bill. However, the memo also notes: “These interest groups often have differing priorities, which may complicate US hemp policymaking”.
1st December 2023
- US - Federal: Senate Banking chairman Sherrod Brown says he will not try to include the Secure And Fair Enforcement Regulation (SAFER) Banking Act in any end-of-year legislation, press reports (subscription required). In years past, attempts were made to include cannabis banking bills in end-of-year legislation that is considered must-pass, such as the National Defense Authorization Act (NDAA), but those efforts failed. This means any attempts to pass the SAFER Banking Act will likely not occur until 2024.
30th November 2023
- US - New Hampshire: A commission tasked with making recommendations on how to regulate recreational cannabis in the state has failed to make any recommendations, press reports. Although a bill that would have allowed state-selected franchisees to sell cannabis with a 15% sales tax was proposed, no consensus was reached. Complicating the matter was governor Chris Sununu threatening at the last minute to veto any bill that allowed more than 15 retail locations and failed to ban political contributions and lobbying by cannabis licensees.
28th November 2023
- Brazil: The Participatory Legislation Commission of the Chamber of Deputies – a committee that receives proposals from associations and organised civil society, with the exception of political parties – will hold a public hearing tomorrow (29th November) to discuss the regulation of medical cannabis and hemp cultivation. A proposal to legalise medical and industrial cannabis has been pending in the Chamber of Deputies since 2021.
28th November 2023
- US - New York: The Cannabis Control Board approved a settlement that could allow for the opening of 436 dispensaries by provisional conditional adult-use retail dispensary programme (CAURD) licensees. The settlement stems from a lawsuit brought by a group of military veterans seeking CAURD licences and must still be approved by the New York Supreme Court.
28th November 2023
- US - Federal: The US Department of Agriculture (USDA) is revoking hemp licences from hemp cultivators who are also cultivating higher-THC cannabis under state-legal cannabis programmes, press reports. Many cultivators in Mississippi and Vermont, at least, have reportedly already lost their hemp licences, while several others in other states have been warned by the USDA that they would lose their hemp licence if they start growing state-legal cannabis. The risk of USDA enforcement appears to be higher in states in which the USDA issues hemp licences directly, though the USDA denies any difference in enforcement. The revocations rely upon USDA hemp regulations which require that hemp cultivation licensees dispose of all non-compliant hemp plants (i.e. those above an acceptable THC level), as they are, by definition, marijuana, a Schedule I drug under federal law.
27th November 2023
- Canada: Health Canada approved the use of Epidiolex as an adjunct therapy for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients aged two or older.
23rd November 2023
- Colombia: Bill 001/2023C amending the Constitution to legalise cannabis was approved yesterday (22nd November) on its third vote in the Senate. The bill, which was approved by 15 votes in the first commission of the Senate, must go through five further debates in order to be passed. The next debate will take place at the Senate plenary.
22nd November 2023
- US - Federal: The Food and Drug Administration (FDA) has issued a warning letter to Discover Health LLC over its products marketed to contain CBD, CBG, HHC, and delta-8 THC. While the letter makes many claims about the products being adulterated, unapproved new drugs, and misbranded drugs, the warning appears to have been triggered by the many health claims made about the products.
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market data
Up-to-date information and insights on brands, pricing and retail across selected markets
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.